NASDAQ: VBIOValion Bio Inc Stock Ownership - Who owns Valion Bio?
Insider buying vs selling
Have Valion Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sheryle Bolton | Director | 2026-04-15 | 10,000 | $1.04 | $10.40kBuy |
| Christina Rizopoulos Valauri | Director | 2026-04-01 | 19,000 | $0.95 | $18.01kBuy |
| Jennifer Ernst | Chief Executive Officer | 2025-12-18 | 5,262 | $1.87 | $9.84kSell |
| Lisa G. Wolf | Chief Financial Officer | 2025-12-18 | 302 | $1.87 | $564.74Sell |
VBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VBIO insiders and whales buy or sell their stock.
VBIO Shareholders
What type of owners hold Valion Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| John Claude | 41.56% | 1,196,000 | $1.21M | Insider |
| Blake Gurfein | 4.17% | 119,979 | $121.18k | Insider |
| Briana Benz | 3.91% | 112,500 | $113.63k | Insider |
| Marex Group PLC | 1.42% | 40,942 | $41.35k | Institution |
| Jennifer Ernst | 1.14% | 32,691 | $33.02k | Insider |
| Ubs Group Ag | 0.68% | 19,659 | $19.86k | Institution |
| Christina Rizopoulos Valauri | 0.66% | 19,000 | $19.19k | Insider |
| Karen Drexler | 0.63% | 18,076 | $18.26k | Insider |
| Susquehanna International Group LLP | 0.51% | 14,639 | $14.79k | Institution |
| Sheryle Bolton | 0.35% | 10,000 | $10.10k | Insider |
VBIO vs Medical Device Stocks
Valion Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.